LSX Biotech Growth CEO Forum

Biotech Growth / Late Growth Stage CEO Forum

2021 session details

Agenda | Past Attendees | Hosts | Book

Open to CEO, Founder, Co-Founder, President, Chairman or c-suite executive (CFO, CBO, CCO, CSO, CMO) of US-based, post-series A-funded, therapeutic Biotech companies.

Free to attend, pre-registration only, Chatham House Rule forum hosted on Zoom where all participants are active discussants. 

  • Benchmark yourself against your peers
  • Uncover key factors of success
  • Share war stories and common challenges
  • Engage in peer-to-peer discussion
  • Make meaningful connections
  • Find new ways to help your business thrive


LSX CEO Forums provide a unique, powerful and valuable space for the candid sharing of ideas and experience between 25-30 CEOs from companies at a similar stage of development. The forum is designed to foster new ideas and create new relationships between attendees so that they can leave with tangible outcomes that will drive their businesses and the sector forward. The forum is an in-person, hollow-square roundtable where all participants are active discussants. It follows a strict Chatham House Rule policy and includes case study peer review and a general discussion focused on brainstorming solutions to the collective challenges of CXOs in the sector.

The forum features 3 x interactive peer review case studies of recent transactions, deals, milestones, or company growth stories which a represented by CEOs or event partners, followed by Q&A and general discussion.

CEO's and/or Event Partners put forward "cases" - either success stories or current challenges and use the group as "consultants" with this format:

  • The Headline - short and enticing.
  • The Nutshell - a concise statement of the issue.
  • The Background - the players, what was at stake, etc.
  • What was tried? What worked and what didn't.
  • Clarifying questions from the group
  • Peer Consultation


Past Attendees:

    CERo Therapeutics     CytoDel    Jubilant Therapeutics    Rallybio    

    Theravecyts     Vigil Neuroscience    Vivo Capital    Geneos Therapeutics 300x    
    Carmell Therapeutics     Insilico Medicine     Colby Pharmaceutical Company    ProNeurogen    
    X-Biotix Therapeutics    KBP Biosciences    American Gene Technologies    Cellphire Therapeutics    
    Celmatix    DepYmed    Alma BioTherapeutics    NomoCan Pharmaceuticals